CY1107326T1 - Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων - Google Patents

Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων

Info

Publication number
CY1107326T1
CY1107326T1 CY20061100736T CY061100736T CY1107326T1 CY 1107326 T1 CY1107326 T1 CY 1107326T1 CY 20061100736 T CY20061100736 T CY 20061100736T CY 061100736 T CY061100736 T CY 061100736T CY 1107326 T1 CY1107326 T1 CY 1107326T1
Authority
CY
Cyprus
Prior art keywords
microparticles
methods
smokes
constructing
absorbent surfaces
Prior art date
Application number
CY20061100736T
Other languages
Greek (el)
English (en)
Inventor
Hagen Derek O'
Manmohan Singh
Gary S Ott
John Barackman
Jina Kazzaz
Original Assignee
Novartis Vaccines And Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines And Diagnostics, Inc. filed Critical Novartis Vaccines And Diagnostics, Inc.
Publication of CY1107326T1 publication Critical patent/CY1107326T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Steroid Compounds (AREA)
CY20061100736T 1998-07-29 2006-06-05 Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων CY1107326T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12453398A 1998-07-29 1998-07-29
US28585599A 1999-04-02 1999-04-02
EP99937664A EP1100468B1 (en) 1998-07-29 1999-07-29 Microparticles with adsorbent surfaces, methods of making same, and uses thereof

Publications (1)

Publication Number Publication Date
CY1107326T1 true CY1107326T1 (el) 2012-11-21

Family

ID=26822700

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100736T CY1107326T1 (el) 1998-07-29 2006-06-05 Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων

Country Status (12)

Country Link
EP (1) EP1100468B1 (https=)
JP (2) JP4601168B2 (https=)
AT (1) ATE321535T1 (https=)
AU (1) AU763975B2 (https=)
CA (1) CA2338646C (https=)
CY (1) CY1107326T1 (https=)
DE (1) DE69930642T2 (https=)
DK (1) DK1100468T3 (https=)
ES (1) ES2260923T3 (https=)
NZ (1) NZ509853A (https=)
PT (1) PT1100468E (https=)
WO (1) WO2000006123A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8206749B1 (en) 1999-02-26 2012-06-26 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
AU7627601A (en) * 2000-06-29 2002-01-08 Rudiger Marcus Flaig Drug-delivery systems
ATE350015T1 (de) * 2000-09-28 2007-01-15 Novartis Vaccines & Diagnostic Mikropartikelzusammensetzungen und verfahren zu ihrer herstellung
AR045702A1 (es) * 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
US7838015B2 (en) * 2001-10-03 2010-11-23 Novartis Vaccines And Diagnostics, Inc. Adjuvanted meningococcus compositions
CN100354297C (zh) * 2001-10-03 2007-12-12 希龙公司 辅助的脑膜炎球菌组合物
EP2572707A3 (en) 2002-02-20 2013-11-06 Novartis Vaccines and Diagnostics, Inc. Microparticles with adsorbed polypeptide-containing molecules
JP2006502228A (ja) 2002-10-07 2006-01-19 カイロン コーポレイション Ｈｉｖワクチン処方物
AU2003299994A1 (en) 2002-12-27 2004-07-29 Chiron Corporation Immunogenic compositions containing phospholpid
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
EP1631264B8 (en) 2003-06-02 2017-05-24 GlaxoSmithKline Biologicals SA Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
FR2859909B1 (fr) 2003-09-22 2007-09-07 Biomerieux Sa Procede de preparation de microparticules bioresorbables, microparticules obtenues et utilisation
US7899527B2 (en) * 2004-05-13 2011-03-01 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
WO2006050394A2 (en) 2004-11-01 2006-05-11 Novartis Vaccines And Diagnostics Inc. Combination approaches for generating immune responses
ES2434029T3 (es) 2004-11-15 2013-12-13 Novartis Vaccines And Diagnostics, Inc. Composiciones inmunogénicas que contiene antígeno de antrax, micropartículas de polímero biodegradable, y adyuvante inmunológico que contiene polinucleótido
WO2008051245A2 (en) 2005-12-02 2008-05-02 Novartis Ag Nanoparticles for use in immunogenic compositions
WO2007100699A2 (en) 2006-02-24 2007-09-07 Novartis Ag Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
EP3067048B1 (en) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Compositions for inducing immune responses
CA2722765C (en) 2008-04-28 2016-10-04 Novartis Ag Nanoparticles for use in pharmaceutical compositions
CA2762653A1 (en) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
ES2536429T3 (es) * 2010-01-24 2015-05-25 Novartis Ag Micropartículas de polímero biodegradables irradiadas
AU2011258165B2 (en) 2010-05-26 2016-11-17 Selecta Biosciences, Inc. Dose selection of adjuvanted synthetic nanocarriers
KR20130121699A (ko) 2010-05-28 2013-11-06 테트리스 온라인, 인코포레이티드 상호작용 혼성 비동기 컴퓨터 게임 기반구조
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
WO2012061717A1 (en) 2010-11-05 2012-05-10 Selecta Biosciences, Inc. Modified nicotinic compounds and related methods
CA2840965C (en) 2011-07-06 2021-03-02 Novartis Ag Cationic oil-in-water emulsions
SG10201605512WA (en) 2011-07-06 2016-09-29 Novartis Ag Oil-in-water emulsions that contain nucleic acids
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
BR112015021970A2 (pt) 2013-03-14 2017-07-18 Massachusetts Inst Technology composições à base de nanopartículas
CA3246538A1 (en) 2022-03-30 2023-10-05 Evonik Operations Gmbh Formulations composed of cationic lipids and poly(lactic-co-glycolic acid) for the administration of polynucleotides into cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0805678B1 (en) * 1995-01-05 2003-10-29 THE BOARD OF REGENTS acting for and on behalf of THE UNIVERSITY OF MICHIGAN Surface-modified nanoparticles and method of making and using same
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
US5759583A (en) * 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
PT991403E (pt) * 1997-01-30 2003-08-29 Chiron Corp Uso de microparticulas com antigenio adsorvido para estimular respostas imunes

Also Published As

Publication number Publication date
EP1100468A1 (en) 2001-05-23
EP1100468B1 (en) 2006-03-29
HK1035862A1 (en) 2001-12-14
ES2260923T3 (es) 2006-11-01
ATE321535T1 (de) 2006-04-15
CA2338646C (en) 2008-10-07
AU763975B2 (en) 2003-08-07
JP4601168B2 (ja) 2010-12-22
JP2002521425A (ja) 2002-07-16
JP2010168392A (ja) 2010-08-05
DE69930642T2 (de) 2006-12-28
PT1100468E (pt) 2006-07-31
CA2338646A1 (en) 2000-02-10
DK1100468T3 (da) 2006-07-31
DE69930642D1 (de) 2006-05-18
NZ509853A (en) 2003-08-29
WO2000006123A1 (en) 2000-02-10
AU5245299A (en) 2000-02-21

Similar Documents

Publication Publication Date Title
CY1107326T1 (el) Μικροσωματιδια με απορροφητικες επιφανειες, μεθοδοι κατασκευης αυτων και χρησεις αυτων
ES2159523T3 (es) Procedimientos de encapsulado y composiciones de encapsulado reticuladas biocompatibles.
WO1994024187A3 (en) Organosilicon-containing materials useful for biomedical devices
ATE203037T1 (de) Vernetzbare polymere
AU2001291687A1 (en) Polyammonium-polysiloxane compounds, methods for the production and use thereof
ATE394484T1 (de) Smad 6 und dessen anwendungen
PT1056745E (pt) 2-¬trans-(4-aminociclo-hexil)amino|purinas dissubstituidas em 6,9
DE69505713D1 (de) Von perhalogenierten Sultonen abgeleiteten Monomere, sowie aus diesen Monomeren hergestellte Polymere
FR2703053B1 (fr) Oligonucleotides agrafes et semi-agrafes, procede de preparation et applications .
GB9816659D0 (en) Composition useful for softening, cleaning, and personal care applications and processes for the preparation thereof
NO20073914L (no) Biologisk aktive peptider
IT1295183B1 (it) Macchina operatrice, e relativo procedimento, per la lavorazione di corpi piani.
TNSN98105A1 (fr) Une structure absorbante comprenant un polymere hautement absorbant et un article absorbant comprenant la structure absorbante.
EP0679678A3 (de) Staubarme pulverförmige hydrophile Polymere.
TR27866A (tr) Alken polimerleri üretmeye mahsus yöntem.
DE60034885D1 (de) Enzymlauge und verfahren zu deren herstellung, enzymzubereitung, proteasezubereitungen und proteaseproduzierendes bakterium
TR199501584A2 (tr) Mobilya, bilhassa evlerde kullanilan türde mobilya.
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
IT1299948B1 (it) Metodo e dispositivo per la formazione di gruppi di articoli appiattiti.
PT1358159E (pt) Tartrato e fosfato de 3,4 diaminopiridina, as suas composições farmacêuticas e as suas utilizações
IT1292624B1 (it) Macchina operatrice, e relativo procediemento, per la lavorazione di corpi piani.
WO1997039623A3 (en) Improved production of insecticidal proteins
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof
NO980887D0 (no) Formmasser med antikoagulerende egenskaper, deres fremstilling og bearbeiding til gjenstander som finner anvendelser i medisinteknikken
IT1283265B1 (it) Procedimento ricombinante per la produzione in pseudomonas putida del citocromo c551 di pseudomonas aeruginosa.